DOI QR코드

DOI QR Code

Effect of Cancer Symptoms and Fatigue on Chemotherapy-related Cognitive Impairment and Depression in People with Gastrointestinal Cancer

암증상과 피로가 소화기 암 환자의 항암화학요법 관련 인지기능 감퇴와 우울에 미치는 영향

  • Received : 2015.10.22
  • Accepted : 2016.03.30
  • Published : 2016.06.30

Abstract

Purpose: The purpose of this study was to test a hypothetical model of chemotherapy-related cognitive impairment (CRCI) and depression in people with gastrointestinal cancer. Methods: A purposive sample of 198 patients undergoing chemotherapy was recruited from November 2014 to July 2015. The instruments were Everyday Cognition (ECog), Hospital Anxiety Depression Scale (HADS), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), and M. D. Anderson Symptom Inventory-Gastrointestinal Cancer Module. Data were analyzed using descriptive statistics, correlation, and path analysis. Results: CRCI was directly affected by cancer symptoms (${\beta}=.19$, p=.004) and fatigue (${\beta}=.56$, p<.001)($R^2=47.2%$). Depression was directly affected by fatigue (${\beta}=.48$, p<.001) and CRCI (${\beta}=.27$, p<.001). However, The impact of cancer symptoms on depression was confirmed through the mediating effect of CRCI. Conclusion: Results indicate that in patients with gastrointestinal cancer undergoing chemotherapy along with the direct physiologic effects (fatigue, symptoms) of cancer treatment may have altered cognitive function leading to depression.

Keywords

References

  1. Ministry of Health & Welfare, Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2012. Seoul: Ministry of Health & Welfare; 2014. Report No:11-1352000-000145-10.
  2. Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Review of Anticancer Therapy. 2012;12(2):255-269. http://dx.doi.org/10.1586/era.11.202
  3. Kaiser J, Bledowski C, Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex. 2014;54:33-50. http://dx.doi.org/10.1016/j.cortex.2014.01.010
  4. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology. 2002;20(2):485-493. https://doi.org/10.1200/JCO.20.2.485
  5. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews. 2012;38(7):926-934. http://dx.doi.org/10.1016/j.ctrv.2012.05.002
  6. Kanaskie ML. Chemotherapy-related cognitive change: A principle-based concept analysis. Oncology Nursing Forum. 2012;39(3):E241-E248. http://dx.doi.org/10.1188/12.onf.e241-e248
  7. Krynetskiy E, Krynetskaia N, Rihawi D, Wieczerzak K, Ciummo V, Walker E. Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment. Life Sciences. 2013;93(17):605-610. http://dx.doi.org/10.1016/j.lfs.2013.03.013
  8. Hyrien O, Dietrich J, Noble M. Mathematical and experimental approaches to identify and predict the effects of chemotherapy on neuroglial precursors. Cancer Research. 2010;70(24):10051-10059. http://dx.doi.org/10.1158/0008-5472.can-10-1400
  9. de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping. 2012;33(12):2971-2983. http://dx.doi.org/10.1002/hbm.21422
  10. Lange M, Rigal O, Clarisse B, Giffard B, Sevin E, Barillet M, et al. Cognitive dysfunctions in elderly cancer patients: A new challenge for oncologists. Cancer Treatment Reviews. 2014;40(6):810-817. http://dx.doi.org/10.1016/j.ctrv.2014.03.003
  11. Chung BY, Cho EJ. Correlates influencing cognitive impairment in breast cancer patients receiving chemotherapy. Asian Oncology Nursing. 2012;12(3):221-229. http://dx.doi.org/10.5388/aon.2012.12.3.221
  12. Park JH, Bae SH, Jung YS, Jung YM. Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer. Journal of Korean Academy of Nursing. 2015;45(1):118-128. http://dx.doi.org/10.4040/jkan.2015.45.1.118
  13. Hess LM, Insel KC. Chemotherapy-related change in cognitive function: A conceptual model. Oncology Nursing Forum. 2007;34(5):981-994. http://dx.doi.org/10.1188/07.onf.981-994
  14. Vardy J, Tannock I. Cognitive function after chemotherapy in adults with solid tumours. Critical Reviews in Oncology/Hematology. 2007;63(3):183-202. http://dx.doi.org/10.1016/j.critrevonc.2007.06.001
  15. Cella D, Davis K, Breitbart W, Curt G. Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology. 2001;19(14):3385-3391. https://doi.org/10.1200/JCO.2001.19.14.3385
  16. Deimling GT, Kahana B, Bowman KF, Schaefer ML. Cancer survivorship and psychological distress in later life. Psycho-Oncology. 2002;11(6):479-494. http://dx.doi.org/10.1002/pon.614
  17. Mun SB. Basic concepts and applications of structural equation modeling. Seoul: Hakjisa Corp.; 2009.
  18. Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirkendoll KJ, et al. Validation and application of a module of the M. D. Anderson symptom inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer. 2010;116(8):2053-2063. http://dx.doi.org/10.1002/cncr.24920
  19. Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. The Journal of Rheumatology. 2005;32(5):811-819.
  20. Kim H, Yoo HJ, Kim YJ, Han OS, Lee KH, Lee JH, et al. Development and validation of Korean functional assessment cancer therapy-general (FACT-G). The Korean Journal of Clinical Psychology. 2003;22(1):215-229.
  21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12(3):189-198. https://doi.org/10.1016/0022-3956(75)90026-6
  22. Kang Y. A normative study of the Korean-mini mental state examination (K-MMSE) in the elderly. Korean Journal of Psychology. 2006;25(2):1-12.
  23. Prabhu RS, Won M, Shaw EG, Hu C, Brachman DG, Buckner JC, et al. Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: Secondary analysis of RTOG 98-02. Journal of Clinical Oncology. 2014;32(6):535-541. http://dx.doi.org/10.1200/jco.2013.53.1830
  24. Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al. The measurement of everyday cognition (ECog): Scale development and psychometric properties. Neuropsychology. 2008;22(4):531-544. http://dx.doi.org/10.1037/0894-4105.22.4.531
  25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
  26. Oh SM, Min KJ, Park DB. A study on the standardization of the hospital anxiety and depression scale for Koreans: A comparison of normal, depressed and anxious groups. Journal of Korean Neuropsychiatric Association. 1999;38(2):289-296.
  27. Heo J. AMOS structural equation modeling. Seoul: Hannare Publishing Co.; 2013.
  28. Park JG, Park CI, Kim NK. Oncology. Seoul: Ilchokak; 2003.
  29. Kim GD. Impact of climacteric symptoms and fatigue on the quality of life in breast cancer survivors: The mediating effect of cognitive dysfunction. Asian Oncology Nursing. 2014;14(2):58-65. http://dx.doi.org/10.5388/aon.2014.14.2.58
  30. Baek Y, Yi M. Factors influencing quality of life during chemotherapy for colorectal cancer patients in South Korea. Journal of Korean Academy of Nursing. 2015;45(4):604-612. http://dx.doi.org/10.4040/jkan.2015.45.4.604

Cited by

  1. 암 환자를 위한 앱 기반의 인지건강훈련 프로그램의 개발 vol.29, pp.3, 2016, https://doi.org/10.7475/kjan.2017.29.3.266
  2. Symptom Distress and Depression in Patients with Recurrent Gynecologic Cancer Undergoing Chemotherapy: Mediating Effect of Resilience vol.31, pp.1, 2019, https://doi.org/10.7475/kjan.2019.31.1.28
  3. Computerized programs for cancer survivors with cognitive problems: a systematic review vol.13, pp.6, 2016, https://doi.org/10.1007/s11764-019-00807-4
  4. Attitudes About Coping With Fatigue in Patients With Gastric Cancer : A Q-Methodology Study vol.43, pp.1, 2016, https://doi.org/10.1097/sga.0000000000000390